Keyphrases
Soft Tissue Infection
74%
Skin Tissue
72%
Vancomycin
41%
Antibiotics
41%
Skin Structure Infections
35%
Reactive Oxygen Species
32%
Iclaprim
30%
Linezolid
27%
Methicillin-resistant Staphylococcus Aureus
26%
Acute Bacterial Skin
25%
Antimicrobial
22%
Coagulase-negative Staphylococci (CoNS)
20%
Staphylococcus Aureus
20%
Ceftaroline
20%
Epidemiology
18%
Gram-positive Pathogens
18%
Surgihoney
16%
Wound Infection
15%
Honey
14%
Continuous Ambulatory Peritoneal Dialysis
14%
In Vitro Activity
14%
Procalcitonin
14%
Antimicrobial Stewardship
14%
Antibiotic Resistance
14%
Community-acquired
13%
Comorbidity
13%
Peritonitis
13%
Europe
12%
Clinical Outcomes
12%
Gram-positive
11%
Lyme Disease
11%
Antibiotic Stewardship
11%
Antibiotic Use
11%
Antimicrobial Therapy
11%
Early Discharge
10%
Biofilm
10%
Antibacterial Ability
10%
Ciprofloxacin
10%
Diabetic Foot
10%
Randomized Double-blind
10%
Antimicrobial Activity
9%
Aztreonam
9%
Gram-positive Bacteria
9%
C-reactive Protein
9%
Tigecycline
9%
Novel Antimicrobials
8%
Antimicrobial Resistance
8%
Blood Culture
8%
Meticillin-resistant Staphylococcus Aureus
8%
Diarrhea
8%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Soft Tissue Infection
61%
Antiinfective Agent
46%
Vancomycin
38%
Methicillin-Resistant Staphylococcus Aureus
34%
Antibiotics
28%
Infectious Agent
28%
Linezolid
26%
Iclaprim
20%
Staphylococcus Aureus
17%
Diseases
16%
Reactive Oxygen Metabolite
13%
Coagulase Negative Staphylococcus
13%
Ceftaroline Fosamil
13%
Procalcitonin
13%
Wound
13%
Meticillin
11%
Antimicrobial Resistance
11%
Sepsis
11%
Ciprofloxacin
11%
Comorbidity
10%
Peritonitis
9%
Bloodstream Infection
9%
Gram Positive Bacterium
9%
Aztreonam
9%
Antibiotic Therapy
9%
Minimum Inhibitory Concentration
8%
Wound Infection
8%
Tigecycline
8%
Methicillin Resistant Staphylococcus Aureus Infection
8%
Enterococcus
7%
Moxifloxacin
7%
Piperacillin Plus Tazobactam
7%
Antimicrobial Therapy
7%
Lyme Disease
6%
Bacterial Arthritis
6%
Amoxicillin
6%
Clavulanic Acid
6%
Disease Exacerbation
6%
Teicoplanin
6%
Inflammation
6%
Oritavancin
6%
Diabetes Mellitus
5%
Streptococcus pyogenes
5%
Streptococcus Pneumonia
5%
Adverse Event
5%
Surgical Infection
5%
Daptomycin
5%
Gram Positive Infection
5%
Vancomycin-Resistant Enterococcus
5%
Medicine and Dentistry
Infection
67%
Soft Tissue Infection
48%
Antiinfective Agent
32%
Antibiotics
30%
Pathogen
24%
Methicillin Resistant Staphylococcus Aureus
21%
Reactive Oxygen Species
19%
Cohort Effect
17%
Antibiotic Therapy
16%
Diseases
14%
In Vitro
12%
Staphylococcus Aureus
11%
Lyme Borreliosis
11%
Health Care Cost
10%
Procalcitonin
10%
Ceftaroline Fosamil
10%
Skin Structure
9%
Antibiotic Resistance
8%
Bloodstream Infection
8%
Comorbidity
7%
Oxygen Therapy
7%
Antimicrobial Therapy
7%
Randomized Controlled Trial
7%
Intensive Care Unit
7%
Wound
7%
Vancomycin
7%
Clinician
6%
General Practitioner
6%
Emergency Department
6%
Wound Care
6%
Iclaprim
6%
Disease Exacerbation
6%
Wound Infection
6%
Aztreonam
6%
Surgical Infection
6%
Tick Bite
5%
Outpatient
5%
Bacterial Infection
5%
Sepsis
5%
Clinical Trial
5%
Arm
5%
Peripheral Vascular Disease
5%
Community-Acquired Pneumonia
5%
Cesarean Section
5%
Joint Prosthetics
5%
